calmidazolium and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
calmidazolium has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chan, CK; Vanhoutte, PM | 1 |
Other Studies
1 other study(ies) available for calmidazolium and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Secretoneurin facilitates endothelium-dependent relaxations in porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alkanes; Animals; Bradykinin; Calcimycin; Cardiovascular Agents; Coronary Vessels; Endothelium, Vascular; Imidazoles; Indomethacin; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Pyrazoles; Quinolinium Compounds; Secretogranin II; Swine; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |